Literature DB >> 23622135

The epidemiology of pancreatitis and pancreatic cancer.

Dhiraj Yadav1, Albert B Lowenfels.   

Abstract

Acute pancreatitis is one of the most frequent gastrointestinal causes of hospital admission in the United States. Chronic pancreatitis, although lower in incidence, significantly reduces patients' quality of life. Pancreatic cancer is associated with a high mortality rate and is one of the top 5 causes of death from cancer. The burden of pancreatic disorders is expected to increase over time. The risk and etiology of pancreatitis differ with age and sex, and all pancreatic disorders affect the black population more than any other race. Gallstones are the most common cause of acute pancreatitis, and early cholecystectomy eliminates the risk of future attacks. Alcohol continues to be the single most important risk factor for chronic pancreatitis. Smoking is an independent risk factor for acute and chronic pancreatitis, and its effects could synergize with those of alcohol. Significant risk factors for pancreatic cancer include smoking and non-O blood groups. Alcohol abstinence and smoking cessation can alter the progression of pancreatitis and reduce recurrence; smoking cessation is the most effective strategy to reduce the risk of pancreatic cancer.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23622135      PMCID: PMC3662544          DOI: 10.1053/j.gastro.2013.01.068

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  111 in total

1.  Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity.

Authors:  Sarah Navina; Chathur Acharya; James P DeLany; Lidiya S Orlichenko; Catherine J Baty; Sruti S Shiva; Chandra Durgampudi; Jenny M Karlsson; Kenneth Lee; Kyongtae T Bae; Alessandro Furlan; Jaideep Behari; Shiguang Liu; Teresa McHale; Larry Nichols; Georgios Ioannis Papachristou; Dhiraj Yadav; Vijay P Singh
Journal:  Sci Transl Med       Date:  2011-11-02       Impact factor: 17.956

2.  Fruit and vegetable consumption and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Alina Vrieling; Bas A J Verhage; Fränzel J B van Duijnhoven; Mazda Jenab; Kim Overvad; Anne Tjønneland; Anja Olsen; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Rudolf Kaaks; Sabine Rohrmann; Heiner Boeing; Ute Nöthlings; Antonia Trichopoulou; Tountas John; Zilis Dimosthenes; Domenico Palli; Sabina Sieri; Amalia Mattiello; Rosario Tumino; Paolo Vineis; Carla H van Gils; Petra H M Peeters; Dagrun Engeset; Eiliv Lund; Laudina Rodríguez Suárez; Paula Jakszyn; Nerea Larrañaga; María-José Sánchez; María-Dolores Chirlaque; Eva Ardanaz; Jonas Manjer; Björn Lindkvist; Göran Hallmans; Weimin Ye; Sheila Bingham; Kay-Tee Khaw; Andrew Roddam; Tim Key; Paolo Boffetta; Eric J Duell; Dominique S Michaud; Elio Riboli; H Bas Bueno-de-Mesquita
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

3.  Effect of type of alcoholic beverage in causing acute pancreatitis.

Authors:  O Sadr Azodi; N Orsini; Å Andrén-Sandberg; A Wolk
Journal:  Br J Surg       Date:  2011-08-03       Impact factor: 6.939

4.  Incidence of acute pancreatitis does not increase during Oktoberfest, but is higher than previously described in Germany.

Authors:  Veit Phillip; Wolfgang Huber; Frank Hagemes; Sandra Lorenz; Ulrike Matheis; Sigrid Preinfalk; Tibor Schuster; Florian Lippl; Bernd Saugel; Roland M Schmid
Journal:  Clin Gastroenterol Hepatol       Date:  2011-06-30       Impact factor: 11.382

5.  Progression from acute to chronic pancreatitis: prognostic factors, mortality, and natural course.

Authors:  Camilla Nøjgaard; Ulrik Becker; Peter Matzen; Jens Rikardt Andersen; Claus Holst; Flemming Bendtsen
Journal:  Pancreas       Date:  2011-11       Impact factor: 3.327

6.  Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study.

Authors:  Xiang-Lin Tan; Kaye M Reid Lombardo; William R Bamlet; Ann L Oberg; Dennis P Robinson; Kristin E Anderson; Gloria M Petersen
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-29

7.  ABO blood group and chronic pancreatitis risk in the NAPS2 cohort.

Authors:  Julia B Greer; Jessica LaRusch; Randall E Brand; Michael R O'Connell; Dhiraj Yadav; David C Whitcomb
Journal:  Pancreas       Date:  2011-11       Impact factor: 3.327

8.  Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel.

Authors:  Tal Sella; Gabriel Chodick; Micha Barchana; Anthony D Heymann; Avi Porath; Ehud Kokia; Varda Shalev
Journal:  Cancer Causes Control       Date:  2011-08-17       Impact factor: 2.506

9.  ABO blood group and the risk of pancreatic cancer.

Authors:  Brian M Wolpin; Andrew T Chan; Patricia Hartge; Stephen J Chanock; Peter Kraft; David J Hunter; Edward L Giovannucci; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

10.  The recurrence of acute alcohol-associated pancreatitis can be reduced: a randomized controlled trial.

Authors:  Isto Nordback; Hanna Pelli; Riitta Lappalainen-Lehto; Satu Järvinen; Sari Räty; Juhani Sand
Journal:  Gastroenterology       Date:  2008-11-27       Impact factor: 22.682

View more
  570 in total

1.  Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors.

Authors:  Matthew I Confeld; Babak Mamnoon; Li Feng; Heather Jensen-Smith; Priyanka Ray; James Froberg; Jiha Kim; Michael A Hollingsworth; Mohiuddin Quadir; Yongki Choi; Sanku Mallik
Journal:  Mol Pharm       Date:  2020-07-22       Impact factor: 4.939

2.  Activation of AMP-activated protein kinase attenuates ethanol-induced ER/oxidative stress and lipid phenotype in human pancreatic acinar cells.

Authors:  Mukund P Srinivasan; Kamlesh K Bhopale; Anna A Caracheo; Samir M Amer; Shamis Khan; Lata Kaphalia; Gopalakrishnan Loganathan; Appakalai N Balamurugan; Bhupendra S Kaphalia
Journal:  Biochem Pharmacol       Date:  2020-07-25       Impact factor: 5.858

3.  Outcomes of Chronic Pancreatitis in the Emergency Department.

Authors:  Julia McNabb-Baltar; Shadeah L Suleiman; Peter A Banks; Darwin L Conwell
Journal:  Dig Dis Sci       Date:  2018-07-23       Impact factor: 3.199

Review 4.  Chimeric antigen receptor T cell therapy in pancreatic cancer: from research to practice.

Authors:  Vishal Jindal; Ena Arora; Muhammad Masab; Sorab Gupta
Journal:  Med Oncol       Date:  2018-05-04       Impact factor: 3.064

5.  Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat.

Authors:  Gail L Matters; Timothy K Cooper; Christopher O McGovern; Evan L Gilius; Jiangang Liao; Brian M Barth; Mark Kester; Jill P Smith
Journal:  Dig Dis Sci       Date:  2014-05-11       Impact factor: 3.199

Review 6.  Metabolism and epigenetics of pancreatic cancer stem cells.

Authors:  M Perusina Lanfranca; J K Thompson; F Bednar; C Halbrook; C Lyssiotis; B Levi; T L Frankel
Journal:  Semin Cancer Biol       Date:  2018-09-28       Impact factor: 15.707

7.  Quantitation of circulating satellite RNAs in pancreatic cancer patients.

Authors:  Takahiro Kishikawa; Motoyuki Otsuka; Takeshi Yoshikawa; Motoko Ohno; Keisuke Yamamoto; Natsuyo Yamamoto; Ai Kotani; Kazuhiko Koike
Journal:  JCI Insight       Date:  2016-06-02

Review 8.  Tumor cross-talk networks promote growth and support immune evasion in pancreatic cancer.

Authors:  Christopher J Halbrook; Marina Pasca di Magliano; Costas A Lyssiotis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-15       Impact factor: 4.052

9.  Early Versus Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis with Mild Pancreatitis.

Authors:  Lu Wang; Hai-Feng Yu; Tong Guo; Peng Xie; Zhi-Wei Zhang; Ya-Hong Yu
Journal:  Curr Med Sci       Date:  2020-10-29

10.  Dual-phase CT findings of groove pancreatitis.

Authors:  Atif Zaheer; Maera Haider; Satomi Kawamoto; Ralph H Hruban; Elliot K Fishman
Journal:  Eur J Radiol       Date:  2014-05-27       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.